Filing Details
- Accession Number:
- 0001181431-11-004400
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-20 16:16:02
- Reporting Period:
- 2011-01-18
- Filing Date:
- 2011-01-20
- Accepted Time:
- 2011-01-20 16:16:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454983 | S Richard Levy | Experimental Station Route 141 And Henry Clay Rd Wilmington DE 19880 | Evp, Chief Drug Dev&Medical Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-01-18 | 15,000 | $4.19 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-01-18 | 25,310 | $8.19 | 40,310 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-01-18 | 616 | $16.01 | 39,694 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-01-18 | 1,494 | $15.82 | 38,200 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-01-18 | 8,200 | $15.81 | 30,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-01-18 | 13,600 | $15.80 | 16,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-01-18 | 10,000 | $15.79 | 6,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-01-18 | 6,400 | $15.77 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Options | Disposition | 2011-01-18 | 15,000 | $0.00 | 15,000 | $4.19 |
| Common Stock | Incentive Stock Options | Disposition | 2011-01-18 | 25,310 | $0.00 | 25,310 | $8.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-08-17 | No | 4 | M | Direct | |
| 0 | 2014-02-12 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Beginning August 18, 2003, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remainder vesting monthly over three years.
- Beginning February 13, 2004, options become exercisable in 37 installments, with the first installment of 25% vesting after one year and the remainder vesting monthly over three years.
Billionaire Hedge Funds
